Bis-type Triaziquone Induces PARP1-mediated Cell Death in Human NPC/HK1 Nasopharyngeal Carcinoma Cells
Anticancer Research · 2025
DOI: 10.21873/anticanres.17881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Chih-Chun Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Poly (ADP-Ribose) Polymerase-1, Nasopharyngeal Neoplasms, Naphthoquinones.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- Department of Otolaryngology, E-Da Hospital, Kaohsiung, Taiwan, R.O.C.
- School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- Department of Hematology-Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan, R.O.C.
- Department of Biomedical Engineering, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.; yyinmed@isu.edu.tw.
Zitieren
APA
Wang, C. C., Hwang, T. Z., Hsieh, M. C., Kao, T. H., Li, Y., & Lan, Y. Y. (2025). Bis-type Triaziquone Induces PARP1-mediated Cell Death in Human NPC/HK1 Nasopharyngeal Carcinoma Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17881
Vancouver
Wang CC, Hwang TZ, Hsieh MC, Kao TH, Li Y, Lan YY. Bis-type Triaziquone Induces PARP1-mediated Cell Death in Human NPC/HK1 Nasopharyngeal Carcinoma Cells. Anticancer Research. 2025. doi:10.21873/anticanres.17881
BibTeX
@article{Wang2025,
author = {Wang, Chih-Chun and Hwang, Tzer-Zen and Hsieh, Meng-Che and Kao, Tzu-Han and Li, Yingxiao and Lan, Yu-Yan},
title = {Bis-type Triaziquone Induces PARP1-mediated Cell Death in Human NPC/HK1 Nasopharyngeal Carcinoma Cells},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17881}
}
EUVIMED